Oncolytics Biotech, Inc (NASDAQ:ONCY)’s traded shares stood at 5.67 million during the latest session, with the company’s beta value hitting 0.78. At the last check today, the stock’s price was $0.43, to imply an increase of 7.29% or $0.03 in intraday trading. The ONCY share’s 52-week high remains $1.53, putting it -255.81% down since that peak but still an impressive 6.98% since price per share fell to its 52-week low of $0.40.
Analysts have given a consensus recommendation of Buy for Oncolytics Biotech, Inc (ONCY), translating to a mean rating of 1.50. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ONCY a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.08.
Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information
After registering a 7.29% upside in the latest session, Oncolytics Biotech, Inc (ONCY) has traded red over the past five days. The 5-day price performance for the stock is -7.78%, and -26.08% over 30 days. With these gigs, the year-to-date price performance is -52.81%.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 23.13% for the past 5-year period. While 2025 is set for a 4.66% return in earnings, projections for the next 5 years are at 6.60% annually.
ONCY Dividends
Oncolytics Biotech, Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is SEEDS INVESTOR LLC with 0.19 million shares, or about 0.2496% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.19 million.
Going by data provided on Mar 31, 2025 , Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund holds roughly 66.94 shares. This is just over 0.08% of the total shares, with a market valuation of $28696.0
